מזומן למניה Petros Pharmaceuticals (PTPI)

Petros Pharmaceuticals is implementing IT tools and digital services to optimize access to its medications. The cash per share on this chart demonstrates the business's liquidity, and this metric has reached the level of 0.00. The generic defense strategy relies on a transition into the OTC segment, while stable demand is supported by the development of telemedicine and direct sales.
פילוחי מדדים מקיפים ואנליטיקה עבור Petros Pharmaceuticals, Inc. (PTPI)

Cash per share determines the volume of a company's liquid assets attributable to a single security. This metric is calculated by dividing the total cash balance by the number of outstanding shares. Analyzing the cash per share ratio allows for an assessment of the business's financial stability and margin of safety. For Petros Pharmaceuticals (PTPI), this reserve is critical when scaling partnerships with telemedicine platforms. Liquidity ensures the seamless development of joint drug distribution projects.